share_log
Reuters ·  Mar 17 10:05
Actuate Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 383

Recommended

Write a comment